189 related articles for article (PubMed ID: 1567159)
21. Drug resistance reversal, anti-mutagenicity and antiretroviral effect of phthalimido- and chloroethyl-phenothiazines.
Motohashi N; Kurihara T; Kawase M; Hevér A; Tanaka M; Szabo D; Nacsa J; Yamanaka W; Kerim A; Molnár J
Anticancer Res; 1997; 17(5A):3537-43. PubMed ID: 9413199
[TBL] [Abstract][Full Text] [Related]
22. Antimutagenicity of benzo[a]phenothiazines in chemically induced mutagenesis.
Tanaka M; Wayda K; Molnár J; Párkányi C; Aaron JJ; Motohashi N
Anticancer Res; 1997; 17(2A):839-42. PubMed ID: 9137417
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxicity and differentiation-inducing activity of phenothiazine and benzo[a]phenothiazine derivatives.
Motohashi N; Sakagami H; Kamata K; Yamamoto Y
Anticancer Res; 1991; 11(5):1933-7. PubMed ID: 1662929
[TBL] [Abstract][Full Text] [Related]
24. Relationship of carcinogenicity, mutagenicity, and K-region reactivity in benz[c]acridines.
Okano T; Horie T; Koike T; Motohashi N
Gan; 1979 Dec; 70(6):749-54. PubMed ID: 535685
[TBL] [Abstract][Full Text] [Related]
25. Relationship between resonance energy and carcinogenic activity of benz[c]acridines.
Motohashi N; Kurihara T; Sakagami H; Molnar J
Anticancer Res; 1992; 12(6B):2105-8. PubMed ID: 1295454
[TBL] [Abstract][Full Text] [Related]
26. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
[TBL] [Abstract][Full Text] [Related]
27. Substituted benz[a]acridines and benz[c]acridines as mammalian topoisomerase poisons.
Makhey D; Yu C; Liu A; Liu LF; LaVoie EJ
Bioorg Med Chem; 2000 May; 8(5):1171-82. PubMed ID: 10882027
[TBL] [Abstract][Full Text] [Related]
28. Radical intensity and carcinogenic activity of benz[c]acridines.
Satoh K; Sakagami H; Kadofuku T; Kurihara T; Motohashi N
Anticancer Res; 1997; 17(5A):3553-7. PubMed ID: 9413201
[TBL] [Abstract][Full Text] [Related]
29. Benzo[b]-1,8-naphthyridine derivatives: synthesis and reversal activity on multidrug resistance.
Misbahi H; Brouant P; Hevér A; Molnár AM; Wolfard K; Spengler G; Mefetah H; Molnár J; Barbe J
Anticancer Res; 2002; 22(4):2097-101. PubMed ID: 12174889
[TBL] [Abstract][Full Text] [Related]
30. Influence of benzo[a]phenothiazines on the element content of two tobacco tissue cultures differing in hormone requirement.
Szabó M; Csiszár J; Rausch H; Molnár J; Motohashi N
Anticancer Res; 1997; 17(3C):2049-56. PubMed ID: 9216663
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of plasmid curing by 9-aminoacridine and two phenothiazines in the presence of proton pump inhibitor 1-(2-benzoxazolyl)-3,3,3-trifluoro-2-propanone.
Spengler G; Miczák A; Hajdú E; Kawase M; Amaral L; Molnár J
Int J Antimicrob Agents; 2003 Sep; 22(3):223-7. PubMed ID: 13678825
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic potential of phenothiazines.
Motohashi N; Kawase M; Satoh K; Sakagami H
Curr Drug Targets; 2006 Sep; 7(9):1055-66. PubMed ID: 17017885
[TBL] [Abstract][Full Text] [Related]
33. [Inactivation of Trypanosoma cruzi trypanothione reductase by phenothiazine cationic free radicals].
Gutierrez Correa J; Fairlamb AH; Stoppani AO
Rev Argent Microbiol; 2001; 33(1):36-46. PubMed ID: 11407019
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationships of phenothiazines and related drugs for inhibition of protein kinase C.
Aftab DT; Ballas LM; Loomis CR; Hait WN
Mol Pharmacol; 1991 Nov; 40(5):798-805. PubMed ID: 1944244
[TBL] [Abstract][Full Text] [Related]
35. The in vitro antitumor assay of "half-mustard type" phenothiazines in screens of AIDS-related leukemia and lymphomas.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Molnár J
Anticancer Res; 1997; 17(5A):3425-9. PubMed ID: 9413181
[TBL] [Abstract][Full Text] [Related]
36. Efficient curing of an Escherichia coli F-prime plasmid by phenothiazines.
Mándi TY; molnár J; Holland IB; Béládi I
Genet Res; 1975 Aug; 26(1):109-11. PubMed ID: 767215
[No Abstract] [Full Text] [Related]
37. Antimicrobial and immunomodulating effects of some phenolic glycosides.
Molnár J; Gunics G; Mucsi I; Koltai M; Petri I; Shoyama Y; Matsumoto M; Nishioka I
Acta Microbiol Hung; 1989; 36(4):425-32. PubMed ID: 2701348
[TBL] [Abstract][Full Text] [Related]
38. Drug-receptor interaction on plasmid elimination by phenothiazines and imipramine in Escherichia coli.
Molnár J; Mándi Y; Földeák S
Acta Microbiol Acad Sci Hung; 1982; 29(1):17-25. PubMed ID: 7046353
[TBL] [Abstract][Full Text] [Related]
39. [The increase of resistance of Staphylococcus and Escherichia coli to some antibiotics and their combinations with DNA-tropic substances].
Brodinova NS; Moroz AF
Antibiotiki; 1970 Sep; 15(9):801-6. PubMed ID: 4099112
[No Abstract] [Full Text] [Related]
40. Correlation between structure and diverse biological activities of "half-mustard type" phenothiazines.
Motohashi N; Kurihara T; Satoh K; Sakagami H; Molnár J
Anticancer Res; 1997; 17(6D):4403-6. PubMed ID: 9494541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
